The University of Chicago Header Logo

Connection

Royce Lee to Aggression

Back to Details
This is a "connection" page, showing publications Royce Lee has written about Aggression.
Royce Lee
Connection Strength
9.071
Aggression
  1. Disordered Aggression and Violence in the United States. J Clin Psychiatry. 2020 03 17; 81(2).
    View in: PubMed
    Score: 0.537
  2. 5-HT2c agonist, lorcaserin, reduces aggressive responding in intermittent explosive disorder: A pilot study. Hum Psychopharmacol. 2019 11; 34(6):e2714.
    View in: PubMed
    Score: 0.525
  3. Comorbidity of personality disorder with intermittent explosive disorder. J Psychiatr Res. 2018 11; 106:15-21.
    View in: PubMed
    Score: 0.480
  4. Intermittent Explosive Disorder and Substance Use Disorder: Analysis of the National Comorbidity Survey Replication Sample. J Clin Psychiatry. 2017 Jun; 78(6):697-702.
    View in: PubMed
    Score: 0.442
  5. Social emotional information processing in adults: Development and psychometrics of a computerized video assessment in healthy controls and aggressive individuals. Psychiatry Res. 2017 Feb; 248:40-47.
    View in: PubMed
    Score: 0.425
  6. Social cognition in Intermittent Explosive Disorder and aggression. J Psychiatr Res. 2016 12; 83:140-150.
    View in: PubMed
    Score: 0.416
  7. Development of a social emotional information processing assessment for adults (SEIP-Q). Aggress Behav. 2017 Jan; 43(1):47-59.
    View in: PubMed
    Score: 0.414
  8. Substance use disorders: Relationship with intermittent explosive disorder and with aggression, anger, and impulsivity. J Psychiatr Res. 2016 10; 81:127-32.
    View in: PubMed
    Score: 0.414
  9. Serotonin and impulsive aggression. CNS Spectr. 2015 Jun; 20(3):295-302.
    View in: PubMed
    Score: 0.385
  10. Emotional intelligence and impulsive aggression in Intermittent Explosive Disorder. J Psychiatr Res. 2015 Feb; 61:135-40.
    View in: PubMed
    Score: 0.371
  11. Intermittent Explosive Disorder and aversive parental care. Psychiatry Res. 2014 Dec 15; 220(1-2):477-82.
    View in: PubMed
    Score: 0.361
  12. Modulation of central serotonin affects emotional information processing in impulsive aggressive personality disorder. J Clin Psychopharmacol. 2012 Jun; 32(3):329-35.
    View in: PubMed
    Score: 0.313
  13. Growth hormone responses to GABAB receptor challenge with baclofen and impulsivity in healthy control and personality disorder subjects. Psychopharmacology (Berl). 2011 May; 215(1):41-8.
    View in: PubMed
    Score: 0.283
  14. Cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid: reciprocal relationships with impulsive aggression in human subjects. J Neural Transm (Vienna). 2010 Feb; 117(2):241-8.
    View in: PubMed
    Score: 0.266
  15. Cerebrospinal fluid oxytocin, life history of aggression, and personality disorder. Psychoneuroendocrinology. 2009 Nov; 34(10):1567-73.
    View in: PubMed
    Score: 0.256
  16. Placebo-controlled, randomized trial of fluoxetine in the treatment of aggression in male intimate partner abusers. Int Clin Psychopharmacol. 2008 Nov; 23(6):337-41.
    View in: PubMed
    Score: 0.244
  17. Cerebrospinal fluid GABA concentration: relationship with impulsivity and history of suicidal behavior, but not aggression, in human subjects. J Psychiatr Res. 2009 Jan; 43(4):353-9.
    View in: PubMed
    Score: 0.236
  18. Neuronal responses in social-emotional information processing in impulsive aggressive individuals. Neuropsychopharmacology. 2022 05; 47(6):1249-1255.
    View in: PubMed
    Score: 0.154
  19. The neuropsychopharmacology of criminality and aggression. Can J Psychiatry. 2001 Feb; 46(1):35-44.
    View in: PubMed
    Score: 0.143
  20. Neuronal responses to adverse social threat in healthy human subjects. J Psychiatr Res. 2021 04; 136:47-53.
    View in: PubMed
    Score: 0.142
  21. Subtypes of aggression in intermittent explosive disorder. J Psychiatr Res. 2019 02; 109:164-172.
    View in: PubMed
    Score: 0.122
  22. Social desirability, deceptive reporting, and awareness of problematic aggression in intermittent explosive disorder compared with non-aggressive healthy and psychiatric controls. Psychiatry Res. 2018 12; 270:20-25.
    View in: PubMed
    Score: 0.120
  23. Reduced frontal grey matter, life history of aggression, and underlying genetic influence. Psychiatry Res Neuroimaging. 2018 01 30; 271:126-134.
    View in: PubMed
    Score: 0.114
  24. Tryptophan, kynurenine, and kynurenine metabolites: Relationship to lifetime aggression and inflammatory markers in human subjects. Psychoneuroendocrinology. 2016 09; 71:189-96.
    View in: PubMed
    Score: 0.103
  25. Toxoplasma gondii infection: relationship with aggression in psychiatric subjects. J Clin Psychiatry. 2016 Mar; 77(3):334-41.
    View in: PubMed
    Score: 0.101
  26. Childhood trauma and parental style: Relationship with markers of inflammation, oxidative stress, and aggression in healthy and personality disordered subjects. Biol Psychol. 2015 Dec; 112:56-65.
    View in: PubMed
    Score: 0.098
  27. Morphometric analysis of amygdla and hippocampus shape in impulsively aggressive and healthy control subjects. J Psychiatr Res. 2015 Oct; 69:80-6.
    View in: PubMed
    Score: 0.097
  28. Cerebrospinal fluid inflammatory cytokines and aggression in personality disordered subjects. Int J Neuropsychopharmacol. 2015 Feb 03; 18(7):pyv001.
    View in: PubMed
    Score: 0.094
  29. Cerebrospinal fluid and plasma C-reactive protein and aggression in personality-disordered subjects: a pilot study. J Neural Transm (Vienna). 2015 Feb; 122(2):321-6.
    View in: PubMed
    Score: 0.091
  30. Relationship between psychopathy, aggression, anger, impulsivity, and intermittent explosive disorder. Aggress Behav. 2014 Nov-Dec; 40(6):526-36.
    View in: PubMed
    Score: 0.089
  31. Elevated plasma inflammatory markers in individuals with intermittent explosive disorder and correlation with aggression in humans. JAMA Psychiatry. 2014 Feb; 71(2):158-65.
    View in: PubMed
    Score: 0.088
  32. Elevated Plasma Oxidative Stress Markers in Individuals With Intermittent Explosive Disorder and Correlation With Aggression in Humans. Biol Psychiatry. 2016 Jan 15; 79(2):127-35.
    View in: PubMed
    Score: 0.088
  33. Cerebrospinal fluid glutamate concentration correlates with impulsive aggression in human subjects. J Psychiatr Res. 2013 Sep; 47(9):1247-53.
    View in: PubMed
    Score: 0.084
  34. Cerebrospinal fluid neuropeptide Y-like immunoreactivity correlates with impulsive aggression in human subjects. Biol Psychiatry. 2012 Dec 15; 72(12):997-1003.
    View in: PubMed
    Score: 0.080
  35. Cerebrospinal fluid 5-hydroxyindolacetic acid correlates directly with negative affective intensity, but not affective lability, in human subjects. Int J Neuropsychopharmacol. 2013 Mar; 16(2):261-9.
    View in: PubMed
    Score: 0.077
  36. Cerebrospinal fluid substance P-like immunoreactivity correlates with aggression in personality disordered subjects. Biol Psychiatry. 2012 Aug 01; 72(3):238-43.
    View in: PubMed
    Score: 0.077
  37. Moderating effects of childhood maltreatment on associations between social information processing and adult aggression. Psychol Med. 2012 Jun; 42(6):1293-304.
    View in: PubMed
    Score: 0.075
  38. Inter-relationship between different platelet measures of 5-HT and their relationship to aggression in human subjects. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Mar 30; 36(2):277-81.
    View in: PubMed
    Score: 0.075
  39. Personality predictors of antiaggressive response to fluoxetine: inverse association with neuroticism and harm avoidance. Int Clin Psychopharmacol. 2011 Sep; 26(5):278-83.
    View in: PubMed
    Score: 0.074
  40. Cortisol responses to ipsapirone challenge correlate with aggression, while basal cortisol levels correlate with impulsivity, in personality disorder and healthy volunteer subjects. J Psychiatr Res. 2010 Oct; 44(14):874-80.
    View in: PubMed
    Score: 0.067
  41. Aggression, suicidality, and intermittent explosive disorder: serotonergic correlates in personality disorder and healthy control subjects. Neuropsychopharmacology. 2010 Jan; 35(2):435-44.
    View in: PubMed
    Score: 0.066
  42. Inverse relationship between numbers of 5-HT transporter binding sites and life history of aggression and intermittent explosive disorder. J Psychiatr Res. 2010 Feb; 44(3):137-42.
    View in: PubMed
    Score: 0.065
  43. Acute tryptophan depletion and self-injurious behavior in aggressive patients and healthy volunteers. Psychopharmacology (Berl). 2009 Mar; 203(1):53-61.
    View in: PubMed
    Score: 0.061
  44. The relationship between impulsive verbal aggression and intermittent explosive disorder. Aggress Behav. 2008 Jan-Feb; 34(1):51-60.
    View in: PubMed
    Score: 0.058
  45. Developmental psychopathology and neurobiology of aggression. Dev Psychopathol. 2005; 17(4):1151-71.
    View in: PubMed
    Score: 0.047
  46. Norepinephrine function in personality disorder: plasma free MHPG correlates inversely with life history of aggression. CNS Spectr. 2003 Oct; 8(10):731-6.
    View in: PubMed
    Score: 0.043
  47. Associations of agression and use of caffeine, alcohol and nicotine in healthy and aggressive individuals. J Psychiatr Res. 2022 02; 146:21-27.
    View in: PubMed
    Score: 0.037
  48. Comorbid intermittent explosive disorder and posttraumatic stress disorder: Clinical correlates and relationship to suicidal behavior. Compr Psychiatry. 2016 10; 70:125-33.
    View in: PubMed
    Score: 0.026
  49. Inflammatory markers and chronic exposure to fluoxetine, divalproex, and placebo in intermittent explosive disorder. Psychiatry Res. 2015 Oct 30; 229(3):844-9.
    View in: PubMed
    Score: 0.024
  50. History of childhood maltreatment in intermittent explosive disorder and suicidal behavior. J Psychiatr Res. 2014 Sep; 56:10-7.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.